Impact Factor 3.644 | CiteScore 3.2
More on impact ›
Submit your manuscript
Scope
Nanobiotechnology has a broad field of appeal, from organ-on-chip technologies to nanobiosensors, from nanodiagnostics to advanced characterisation and imaging tools, from intelligent drug delivery to artificial bioconstructs, and from functional nanostructured surfaces to smart materials and nanofluidics.
Scope
The exploitation of nanotechnology in the development of biomedical devices allows the control of biological entities at previously unreachable levels, down to the single molecule. Living matter, manipulated at the nanoscale, can be thus technologically quantified, controlled, and engineered, for plenty of applications that range from diagnosis and treatment of pathologies to the preparation of nanostructured scaffolds for regenerative medicine purposes.
The technological/biological impact of nanoscale systems, the synthesis and the characterization of nanoscale biomaterials, and the innovative applications of “smart” nanoparticles are just some examples of the driving force of the specialty section “Nanobiotechnology”, within a robust multidisciplinary framework that needs contribution from engineering, chemistry, life science, and materials science.
Nanobiotechnology has a broad field of appeal, from organ-on-chip technologies to nanobiosensors, from nanodiagnostics to advanced characterisation and imaging tools, from intelligent drug delivery to artificial bioconstructs, and from functional nanostructured surfaces to smart materials and nanofluidics. Among all these topics, also nanotoxicology and possible harmful impact of nanomaterials in living organisms should be mentioned: the evaluation of the safety of an innovative nanodevice is, in fact, a process that should start since the very first steps of its concept and design. Particular attention is finally dedicated to the translational and regulatory aspects of nanobiomedical devices, envisioning their practical applications in the future clinical practice.
Indexed in: PubMed, PubMed Central (PMC), Scopus, Web of Science Science Citation Index Expanded (SCIE), Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), Semantic Scholar, Ulrich's Periodicals Directory, CLOCKSS, EI Compendex, OpenAIRE, Zetoc
PMCID: all published articles receive a PMCID
Nanobiotechnology welcomes submissions of the following article types: Brief Research Report, Case Report, Correction, Data Report, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Nanobiotechnology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This section has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact bioengineering.editorial.office@frontiersin.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact Bioengineering@frontiersin.org
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
For technical issues, please visit our Frontiers Help Center, or contact our IT HelpDesk team at support@frontiersin.org